JP6960399B2 - ドライアイを治療または防止する方法 - Google Patents

ドライアイを治療または防止する方法 Download PDF

Info

Publication number
JP6960399B2
JP6960399B2 JP2018517468A JP2018517468A JP6960399B2 JP 6960399 B2 JP6960399 B2 JP 6960399B2 JP 2018517468 A JP2018517468 A JP 2018517468A JP 2018517468 A JP2018517468 A JP 2018517468A JP 6960399 B2 JP6960399 B2 JP 6960399B2
Authority
JP
Japan
Prior art keywords
eye
formula
compound
dry eye
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2018517468A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018517776A5 (https=
JP2018517776A (ja
Inventor
ウー・ロン−ツン
ホーン・リン−イア
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2018517776A publication Critical patent/JP2018517776A/ja
Publication of JP2018517776A5 publication Critical patent/JP2018517776A5/ja
Application granted granted Critical
Publication of JP6960399B2 publication Critical patent/JP6960399B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
JP2018517468A 2015-06-16 2016-06-16 ドライアイを治療または防止する方法 Active JP6960399B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562180450P 2015-06-16 2015-06-16
US62/180,450 2015-06-16
PCT/CN2016/000309 WO2016201953A1 (en) 2015-06-16 2016-06-16 Method for treating or preventing dry eyes

Publications (3)

Publication Number Publication Date
JP2018517776A JP2018517776A (ja) 2018-07-05
JP2018517776A5 JP2018517776A5 (https=) 2019-07-18
JP6960399B2 true JP6960399B2 (ja) 2021-11-05

Family

ID=57544797

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018517468A Active JP6960399B2 (ja) 2015-06-16 2016-06-16 ドライアイを治療または防止する方法

Country Status (9)

Country Link
US (1) US10383885B2 (https=)
EP (1) EP3310361B1 (https=)
JP (1) JP6960399B2 (https=)
KR (1) KR102606948B1 (https=)
CN (1) CN107921053B (https=)
AU (1) AU2016279139B2 (https=)
CA (1) CA2989341C (https=)
TW (1) TWI649083B (https=)
WO (1) WO2016201953A1 (https=)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1332726A (zh) * 1998-11-02 2002-01-23 卫福有限公司 吡咯烷化合物及其药物用途
NZ517556A (en) * 1999-09-06 2003-08-29 Ono Pharmaceutical Co N-[o-(p-pivaloyloxybenzenesulphonyl-amino)benzoyl]glycine as preventive and therapeutic agents for eye diseases
CN1257176C (zh) * 2003-10-24 2006-05-24 广州中医药大学热带医学研究所 2，3，5，4＇－四羟基二苯乙烯－2－O－β－D－葡萄糖苷在制备降血脂药物中的应用
US20060292099A1 (en) * 2005-05-25 2006-12-28 Michael Milburn Treatment of eye disorders with sirtuin modulators
US20100160243A1 (en) * 2008-12-24 2010-06-24 National Yang-Ming University Compounds and methods for enhancing erythropoiesis
CN101966193B (zh) * 2010-10-29 2012-05-23 西南交通大学 2,3,5,4’-四羟基二苯乙烯-2-O-β-D-葡萄糖苷在制备治疗抑郁症药物中的应用
US20120164242A1 (en) * 2010-12-27 2012-06-28 Wen-Jen Yu Novel methods for modulating melanin production
AU2013384234A1 (en) * 2013-03-28 2015-10-15 Rong-Tsun Wu Composition and method for inducing EPO-mediated haemoglobin expression and mitochondrial biogenesis in nonhaematopoietic cell
CN103524576A (zh) * 2013-08-12 2014-01-22 天津中医药大学 2,3,5,4′-四羟基二苯乙烯-2-O-β-D-葡萄糖苷的分离纯化工艺

Also Published As

Publication number Publication date
KR20180019151A (ko) 2018-02-23
AU2016279139B2 (en) 2020-09-10
EP3310361A1 (en) 2018-04-25
CA2989341C (en) 2021-12-07
TW201717965A (zh) 2017-06-01
AU2016279139A1 (en) 2018-01-04
EP3310361A4 (en) 2019-01-23
WO2016201953A1 (en) 2016-12-22
TWI649083B (zh) 2019-02-01
CN107921053A (zh) 2018-04-17
US10383885B2 (en) 2019-08-20
JP2018517776A (ja) 2018-07-05
US20180193369A1 (en) 2018-07-12
CA2989341A1 (en) 2016-12-22
KR102606948B1 (ko) 2023-11-27
CN107921053B (zh) 2020-09-01
EP3310361B1 (en) 2022-05-11

Similar Documents

Publication Publication Date Title
CA2909806C (en) Oral pharmaceutical composition for preventing or treating dry eye syndrome comprising rebamipide or a prodrug thereof
Lazreg et al. Efficacy and safety of preservative-free timolol 0.1% gel in open-angle glaucoma and ocular hypertension in treatment-naïve patients and patients intolerant to other hypotensive medications
KR20130099926A (ko) 염증성 눈질환의 치료/예방용 화합물
CN107735091B (zh) 包含伊马替尼作为活性成分的用于预防和治疗干眼病的药物组合物
KR102578102B1 (ko) 엔도텔린 수용체 길항제의 국소 안용 제형
CN116367829A (zh) 用于干眼的预防剂、改善剂和治疗剂
EP3968949A1 (en) Triamcinolone acetonide-loaded liposomes topical ophthalmic formulations for prevention of macular thickening and its associated visual outcomes after lens surgery
JP6960399B2 (ja) ドライアイを治療または防止する方法
JP7637430B2 (ja) 新規な眼球乾燥症治療用薬学的組成物
US20250360185A1 (en) Compositions comprising pedf-derived short peptides for the treatment of dry eye diseases
CN111632128B (zh) 短链胜肽组合物在预防或治疗干眼症的应用
WO2025140240A1 (zh) 一种用于治疗和/或预防角膜损伤的药物组合物和方法
WO2023048174A1 (ja) 角膜疾患治療剤
Daull et al. Cationic oil‐in‐water emulsions protect and restore function of the injured ocular surface
Polak Drugs used in ocular treatment

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190614

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190614

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200602

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20200828

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201027

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210316

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210525

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20210928

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20211011

R150 Certificate of patent or registration of utility model

Ref document number: 6960399

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250